TEVA Pharmaceuticals is a worldwide pharmaceutical company. They will be responsible for the distribution of the vaccine in Israel and the rest of the world. Galena will receive a royalty on all sales of the drug, once it is approved for use. Phase III trials will start soon in Israel. Currently, there are open trials in the United States and Canada.
Are the #'s already agreed upon? Does management know the potential?
time to go for it, just figure out which beat down oil guys will double first. Give me 3 picks to evaluate. Mine are bte, crk bbg.
Sure it is easy to lose on these but on the flip side there is a double around somewhere.
Other oil producers whose debt levels are among the highest in Canada are Paramount Resources Ltd. and Baytex Energy Corp. If oil stays low they may have to sell off property or be consumed.
Can't argue with that, still accumulating for future returns. I live in the future, this will return to $8+ dividends along the way.
If I am not mistaken, Dr. Mittendorf used basically the same wording in one of her presentations. She also inferred that there is no reason any cancer cells with a pronounced Her2 compliment should not be considered prime candidates for Neuvax treatment.
darn it! You had to spoil the fun. Who cares, day after day after day it goes, on and on until.....time has arrived for the announcement everyone (longs) have been waiting for.
I agree fwiw, it is the nature of the market. Accumulation at this level, K's of shares will pay off handsomely. Pet rocks like to grow when no one is watching.
It's great to be positive on evtn, however for the people who have been here YEARS and seen nothing but decreasing pps and lack of sales from management reality says we made a mistake in this venture. Not a lot of "hope" left just waiting for the last ship to ship out.
Partnership means up front buy in, say $500,000,000. With positive results that will be the low end. What do you think the pps will be then.